 | • レポートコード：D0804-10310 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ポリペプチド薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ポリペプチド薬の種類別市場規模（注射、経鼻投与、肺投与、経口投与、経皮投与）、用途別市場規模（免疫調節薬（アレルギー感染症、免疫）、消化器系薬（消化器系）、骨・結合組織系（甲状腺ホルモン剤）、婦人科・産科薬、腫瘍薬、泌尿器系薬、代謝薬（インスリン、その他血糖降下薬））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、SciClone Pharmaceuticals、Ipsen PHarma Biotech、Merck Serono、AstraZeneca、Ferring Pharmaceuticals、Roche、Asahi Kasei、Lilly、Takeda、Sanofi ・地域別グローバル市場分析 2015年-2020年 ・ポリペプチド薬の北米市場（アメリカ、カナダ、メキシコ） ・ポリペプチド薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ポリペプチド薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ポリペプチド薬の南米市場（ブラジル、アルゼンチン） ・ポリペプチド薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：注射、経鼻投与、肺投与、経口投与、経皮投与 ・用途別分析：免疫調節薬（アレルギー感染症、免疫）、消化器系薬（消化器系）、骨・結合組織系（甲状腺ホルモン剤）、婦人科・産科薬、腫瘍薬、泌尿器系薬、代謝薬（インスリン、その他血糖降下薬） ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Polypeptide Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Polypeptide Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Polypeptide Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Polypeptide Drug market has been segmented into
Injection
Nasal Administration
Lung Administration
Oral Administration
Transdermal Administration
By Application, Polypeptide Drug has been segmented into:
Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug
Urinary System Drug
Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Polypeptide Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Polypeptide Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Polypeptide Drug market.
The report offers in-depth assessment of the growth and other aspects of the Polypeptide Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Polypeptide Drug Market Share Analysis
Polypeptide Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Polypeptide Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Polypeptide Drug sales, revenue and market share for each player covered in this report.
The major players covered in Polypeptide Drug are:
Novartis
SciClone Pharmaceuticals
Ipsen PHarma Biotech
Merck Serono
AstraZeneca
Ferring Pharmaceuticals
Roche
Asahi Kasei
Lilly
Takeda
Sanofi
Among other players domestic and global, Polypeptide Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Polypeptide Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Polypeptide Drug, with price, sales, revenue and global market share of Polypeptide Drug in 2018 and 2019.
Chapter 3, the Polypeptide Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Polypeptide Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Polypeptide Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Polypeptide Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Polypeptide Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Polypeptide Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Injection
1.2.3 Nasal Administration
1.2.4 Lung Administration
1.2.5 Oral Administration
1.2.6 Transdermal Administration
1.3 Market Analysis by Application
1.3.1 Overview: Global Polypeptide Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)
1.3.3 Digestive System Drugs (Gastrointestinal Type)
1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
1.3.5 Gynecologic or Obstetric Drug
1.3.6 Tumor Drug
1.3.7 Urinary System Drug
1.3.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
1.4 Overview of Global Polypeptide Drug Market
1.4.1 Global Polypeptide Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 SciClone Pharmaceuticals
2.2.1 SciClone Pharmaceuticals Details
2.2.2 SciClone Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 SciClone Pharmaceuticals SWOT Analysis
2.2.4 SciClone Pharmaceuticals Product and Services
2.2.5 SciClone Pharmaceuticals Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ipsen PHarma Biotech
2.3.1 Ipsen PHarma Biotech Details
2.3.2 Ipsen PHarma Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Ipsen PHarma Biotech SWOT Analysis
2.3.4 Ipsen PHarma Biotech Product and Services
2.3.5 Ipsen PHarma Biotech Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck Serono
2.4.1 Merck Serono Details
2.4.2 Merck Serono Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck Serono SWOT Analysis
2.4.4 Merck Serono Product and Services
2.4.5 Merck Serono Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AstraZeneca SWOT Analysis
2.5.4 AstraZeneca Product and Services
2.5.5 AstraZeneca Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Ferring Pharmaceuticals
2.6.1 Ferring Pharmaceuticals Details
2.6.2 Ferring Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Ferring Pharmaceuticals SWOT Analysis
2.6.4 Ferring Pharmaceuticals Product and Services
2.6.5 Ferring Pharmaceuticals Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Roche SWOT Analysis
2.7.4 Roche Product and Services
2.7.5 Roche Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Asahi Kasei
2.8.1 Asahi Kasei Details
2.8.2 Asahi Kasei Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Asahi Kasei SWOT Analysis
2.8.4 Asahi Kasei Product and Services
2.8.5 Asahi Kasei Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Lilly
2.9.1 Lilly Details
2.9.2 Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Lilly SWOT Analysis
2.9.4 Lilly Product and Services
2.9.5 Lilly Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Takeda SWOT Analysis
2.10.4 Takeda Product and Services
2.10.5 Takeda Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sanofi SWOT Analysis
2.11.4 Sanofi Product and Services
2.11.5 Sanofi Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Polypeptide Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Polypeptide Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Polypeptide Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Polypeptide Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Polypeptide Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Polypeptide Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Polypeptide Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Polypeptide Drug Sales and Growth Rate (2015-2020)
4.3 Europe Polypeptide Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Polypeptide Drug Sales and Growth Rate (2015-2020)
4.5 South America Polypeptide Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Polypeptide Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Polypeptide Drug Sales, Revenue and Market Share by Country
5.1.1 North America Polypeptide Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Polypeptide Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Polypeptide Drug Sales and Growth Rate (2015-2020)
5.3 Canada Polypeptide Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Polypeptide Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Polypeptide Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Polypeptide Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Polypeptide Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Polypeptide Drug Sales and Growth Rate (2015-2020)
6.3 UK Polypeptide Drug Sales and Growth Rate (2015-2020)
6.4 France Polypeptide Drug Sales and Growth Rate (2015-2020)
6.5 Russia Polypeptide Drug Sales and Growth Rate (2015-2020)
6.6 Italy Polypeptide Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Polypeptide Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Polypeptide Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Polypeptide Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Polypeptide Drug Sales and Growth Rate (2015-2020)
7.3 Japan Polypeptide Drug Sales and Growth Rate (2015-2020)
7.4 Korea Polypeptide Drug Sales and Growth Rate (2015-2020)
7.5 India Polypeptide Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Polypeptide Drug Sales and Growth Rate (2015-2020)
7.7 Australia Polypeptide Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Polypeptide Drug Sales, Revenue and Market Share by Country
8.1.1 South America Polypeptide Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Polypeptide Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Polypeptide Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Polypeptide Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Polypeptide Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Polypeptide Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Polypeptide Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Polypeptide Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Polypeptide Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Polypeptide Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Polypeptide Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Polypeptide Drug Sales and Market Share by Type (2015-2020)
10.2 Global Polypeptide Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Polypeptide Drug Price by Type (2015-2020)
11 Global Polypeptide Drug Market Segment by Application
11.1 Global Polypeptide Drug Sales Market Share by Application (2015-2020)
11.2 Global Polypeptide Drug Revenue Market Share by Application (2015-2020)
11.3 Global Polypeptide Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Polypeptide Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Polypeptide Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Polypeptide Drug Market Forecast (2021-2025)
12.2.2 Europe Polypeptide Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Polypeptide Drug Market Forecast (2021-2025)
12.2.4 South America Polypeptide Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Polypeptide Drug Market Forecast (2021-2025)
12.3 Polypeptide Drug Market Forecast by Type (2021-2025)
12.3.1 Global Polypeptide Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Polypeptide Drug Market Share Forecast by Type (2021-2025)
12.4 Polypeptide Drug Market Forecast by Application (2021-2025)
12.4.1 Global Polypeptide Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Polypeptide Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Polypeptide Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Polypeptide Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Polypeptide Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Polypeptide Drug Major Business
Table 9. Novartis Polypeptide Drug Total Revenue (USD Million) (2017-2018)
Table 10. Novartis SWOT Analysis
Table 11. Novartis Polypeptide Drug Product and Services
Table 12. Novartis Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. SciClone Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. SciClone Pharmaceuticals Polypeptide Drug Major Business
Table 15. SciClone Pharmaceuticals Polypeptide Drug Total Revenue (USD Million) (2017-2018)
Table 16. SciClone Pharmaceuticals SWOT Analysis
Table 17. SciClone Pharmaceuticals Polypeptide Drug Product and Services
Table 18. SciClone Pharmaceuticals Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Ipsen PHarma Biotech Basic Information, Manufacturing Base and Competitors
Table 20. Ipsen PHarma Biotech Polypeptide Drug Major Business
Table 21. Ipsen PHarma Biotech Polypeptide Drug Total Revenue (USD Million) (2017-2018)
Table 22. Ipsen PHarma Biotech SWOT Analysis
Table 23. Ipsen PHarma Biotech Polypeptide Drug Product and Services
Table 24. Ipsen PHarma Biotech Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merck Serono Basic Information, Manufacturing Base and Competitors
Table 26. Merck Serono Polypeptide Drug Major Business
Table 27. Merck Serono Polypeptide Drug Total Revenue (USD Million) (2017-2018)
Table 28. Merck Serono SWOT Analysis
Table 29. Merck Serono Polypeptide Drug Product and Services
Table 30. Merck Serono Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Polypeptide Drug Major Business
Table 33. AstraZeneca Polypeptide Drug Total Revenue (USD Million) (2017-2018)
Table 34. AstraZeneca SWOT Analysis
Table 35. AstraZeneca Polypeptide Drug Product and Services
Table 36. AstraZeneca Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 38. Ferring Pharmaceuticals Polypeptide Drug Major Business
Table 39. Ferring Pharmaceuticals Polypeptide Drug Total Revenue (USD Million) (2017-2018)
Table 40. Ferring Pharmaceuticals SWOT Analysis
Table 41. Ferring Pharmaceuticals Polypeptide Drug Product and Services
Table 42. Ferring Pharmaceuticals Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Roche Basic Information, Manufacturing Base and Competitors
Table 44. Roche Polypeptide Drug Major Business
Table 45. Roche Polypeptide Drug Total Revenue (USD Million) (2017-2018)
Table 46. Roche SWOT Analysis
Table 47. Roche Polypeptide Drug Product and Services
Table 48. Roche Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Asahi Kasei Basic Information, Manufacturing Base and Competitors
Table 50. Asahi Kasei Polypeptide Drug Major Business
Table 51. Asahi Kasei Polypeptide Drug Total Revenue (USD Million) (2017-2018)
Table 52. Asahi Kasei SWOT Analysis
Table 53. Asahi Kasei Polypeptide Drug Product and Services
Table 54. Asahi Kasei Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Lilly Basic Information, Manufacturing Base and Competitors
Table 56. Lilly Polypeptide Drug Major Business
Table 57. Lilly Polypeptide Drug Total Revenue (USD Million) (2017-2018)
Table 58. Lilly SWOT Analysis
Table 59. Lilly Polypeptide Drug Product and Services
Table 60. Lilly Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Takeda Basic Information, Manufacturing Base and Competitors
Table 62. Takeda Polypeptide Drug Major Business
Table 63. Takeda Polypeptide Drug Total Revenue (USD Million) (2017-2018)
Table 64. Takeda SWOT Analysis
Table 65. Takeda Polypeptide Drug Product and Services
Table 66. Takeda Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Polypeptide Drug Major Business
Table 69. Sanofi Polypeptide Drug Total Revenue (USD Million) (2017-2018)
Table 70. Sanofi SWOT Analysis
Table 71. Sanofi Polypeptide Drug Product and Services
Table 72. Sanofi Polypeptide Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Polypeptide Drug Sales by Manufacturer (2018-2019) (MT)
Table 74. Global Polypeptide Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Polypeptide Drug Sales by Regions (2015-2020) (MT)
Table 76. Global Polypeptide Drug Sales Market Share by Regions (2015-2020)
Table 77. Global Polypeptide Drug Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Polypeptide Drug Sales by Countries (2015-2020) (MT)
Table 79. North America Polypeptide Drug Sales Market Share by Countries (2015-2020)
Table 80. North America Polypeptide Drug Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Polypeptide Drug Revenue Market Share by Countries (2015-2020)
Table 82. Europe Polypeptide Drug Sales by Countries (2015-2020) (MT)
Table 83. Europe Polypeptide Drug Sales Market Share by Countries (2015-2020)
Table 84. Europe Polypeptide Drug Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Polypeptide Drug Sales by Regions (2015-2020) (MT)
Table 86. Asia-Pacific Polypeptide Drug Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Polypeptide Drug Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Polypeptide Drug Sales by Countries (2015-2020) (MT)
Table 89. South America Polypeptide Drug Sales Market Share by Countries (2015-2020)
Table 90. South America Polypeptide Drug Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Polypeptide Drug Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Polypeptide Drug Sales by Countries (2015-2020) (MT)
Table 93. Middle East & Africa Polypeptide Drug Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Polypeptide Drug Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Polypeptide Drug Revenue Market Share by Countries (2015-2020)
Table 96. Global Polypeptide Drug Sales by Type (2015-2020) (MT)
Table 97. Global Polypeptide Drug Sales Share by Type (2015-2020)
Table 98. Global Polypeptide Drug Revenue by Type (2015-2020) (USD Million)
Table 99. Global Polypeptide Drug Revenue Share by Type (2015-2020)
Table 100. Global Polypeptide Drug Sales by Application (2015-2020) (MT)
Table 101. Global Polypeptide Drug Sales Share by Application (2015-2020)
Table 102. Global Polypeptide Drug Sales Forecast by Regions (2021-2025) (MT)
Table 103. Global Polypeptide Drug Market Share Forecast by Regions (2021-2025)
Table 104. Global Polypeptide Drug Sales Forecast by Type (2021-2025) (MT)
Table 105. Global Polypeptide Drug Market Share Forecast by Type (2021-2025)
Table 106. Global Polypeptide Drug Sales Forecast by Application (2021-2025)
Table 107. Global Polypeptide Drug Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Polypeptide Drug Picture
Figure 2. Global Sales Market Share of Polypeptide Drug by Type in 2019
Figure 3. Injection Picture
Figure 4. Nasal Administration Picture
Figure 5. Lung Administration Picture
Figure 6. Oral Administration Picture
Figure 7. Transdermal Administration Picture
Figure 8. Polypeptide Drug Sales Market Share by Application in 2018
Figure 9. Immunity Regulating Medicine (Allergy Infection and Immune) Picture
Figure 10. Digestive System Drugs (Gastrointestinal Type) Picture
Figure 11. Bone and Connective Tissue Types (Thyroid hormones Drug) Picture
Figure 12. Gynecologic or Obstetric Drug Picture
Figure 13. Tumor Drug Picture
Figure 14. Urinary System Drug Picture
Figure 15. Metabolic Drug (Insulin and Other Hypoglycemic Agents) Picture
Figure 16. Global Polypeptide Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Polypeptide Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Polypeptide Drug Sales Market Share by Manufacturer in 2019
Figure 37. Global Polypeptide Drug Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Polypeptide Drug Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Polypeptide Drug Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 42. Global Polypeptide Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Polypeptide Drug Revenue Market Share by Regions (2015-2020)
Figure 44. Global Polypeptide Drug Revenue Market Share by Regions in 2018
Figure 45. North America Polypeptide Drug Sales and Growth Rate (2015-2020)
Figure 46. Europe Polypeptide Drug Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Polypeptide Drug Sales and Growth Rate (2015-2020)
Figure 48. South America Polypeptide Drug Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Polypeptide Drug Sales and Growth Rate (2015-2020)
Figure 50. North America Polypeptide Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Polypeptide Drug Sales Market Share by Countries (2015-2020)
Figure 52. North America Polypeptide Drug Sales Market Share by Countries in 2018
Figure 53. North America Polypeptide Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Polypeptide Drug Revenue Market Share by Countries in 2018
Figure 55. United States Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 56. Canada Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 57. Mexico Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 58. Europe Polypeptide Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Polypeptide Drug Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Polypeptide Drug Revenue Market Share by Countries in 2019
Figure 61. Germany Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 62. UK Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 63. France Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 64. Russia Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 65. Italy Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 66. Asia-Pacific Polypeptide Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Polypeptide Drug Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Polypeptide Drug Revenue Market Share by Regions 2019
Figure 69. China Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 70. Japan Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 71. Korea Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 72. India Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 73. Southeast Asia Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 74. South America Polypeptide Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Polypeptide Drug Sales Market Share by Countries in 2019
Figure 76. South America Polypeptide Drug Revenue Market Share by Countries in 2019
Figure 77. Brazil Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 78. Argentina Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 79. Middle East and Africa Polypeptide Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Polypeptide Drug Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Polypeptide Drug Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Polypeptide Drug Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 84. Egypt Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 85. Turkey Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 86. South Africa Polypeptide Drug Sales and Growth Rate (2015-2020) (MT)
Figure 87. Global Polypeptide Drug Sales and Growth Rate (2021-2025) (MT)
Figure 88. Global Polypeptide Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Polypeptide Drug Market Forecast (2021-2025) (MT)
Figure 90. Europe Sales Polypeptide Drug Market Forecast (2021-2025) (MT)
Figure 91. Asia-Pacific Sales Polypeptide Drug Market Forecast (2021-2025) (MT)
Figure 92. South America Sales Polypeptide Drug Market Forecast (2021-2025) (MT)
Figure 93. Middle East & Africa Sales Polypeptide Drug Market Forecast (2021-2025) (MT)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
輸液セットの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Administration Sets market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Administration Sets marke…- 経腸栄養投与セットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Enteral Feeding Administration Sets market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Enteral F…
- 福利管理サービスの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Benefits Administration Service market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 分析実験室サービスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Analytical Laboratory Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD 320.1 million by 2025, from USD 234.1 million in 2019. The Analyti…
- 注射用筋肉アミノ酸およびペプチドおよびヌクレオシドの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Muscular Amino Acid and Peptides and Nucleosides for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global …